Abstract
Background: Whilst there is a growing body of evidence relating to the effectiveness of early detection and early intervention services there have been relatively few studies which have provided information on whether they are cost-effective.
Aim: The aim of this paper is to review the cost-effectiveness evidence for early detection and early intervention in psychosis.
Methods: Full economic evaluations, cost studies, and studies which do not report costs but do provide important resource use information were included in the review.
Results: All cost effectiveness analysis to date suggest that it is possible to offer help early in the development of psychosis in a cost effective manner.
Conclusions: The potential longer term economic benefits of early detection and early intervention are required.
Original language | English |
---|---|
Pages (from-to) | 592-595 |
Number of pages | 4 |
Journal | Current Pharmaceutical Design |
Volume | 18 |
Issue number | 4 |
DOIs | |
Publication status | Published - Feb 2012 |
Keywords
- Humans
- Early Medical Intervention
- Cost-Benefit Analysis
- Psychotic Disorders
- Time Factors
- Early Diagnosis